Science

Elon Musk’s Neuralink achieves historic milestone: Paralyzed man plays online chess with ‘The Force’ – Times of India

[ad_1]

NEW DELHI: Elon Musk has unveiled an extraordinary development in brain-computer interface technology through his company Neuralink, showcasing a paraplegic man controlling a computer cursor and engaging in a chess game merely through thought. The individual, 29-year-old Noland Arbaugh, demonstrates the ability to manipulate digital objects without physical movement, declaring, “See that cursor on the screen? That’s all me…it’s all brainpower.”
Arbaugh’s interaction with technology comes eight years after a life-altering accident that rendered him paralyzed from the shoulders down. This significant milestone was captured in a video, illustrating his ability to navigate a chess game using his mind, a feat he described as akin to using ‘The Force’ from Star Wars.

Neuralink, which Musk established as a medical research entity in 2016, aims to revolutionize the way individuals with disabilities interact with the world. The technology involves a sophisticated implantation process where a robot inserts thread-like electrodes into the brain, enabling direct communication between neural activity and computing devices.
Arbaugh recounted his surgical experience as “super easy,” emphasizing the non-invasiveness and simplicity of the procedure, which reportedly does not require general anesthesia and allows for same-day return home.
Reflecting on the transformative impact of Neuralink, Arbaugh shared his renewed ability to engage in activities like playing chess, which he had enjoyed before his accident. He expressed gratitude and astonishment at being part of the pioneering project, stating, “I’m so freaking lucky to be a part of this, everyday it feels like we’re learning new stuff.”
Kip Ludwig, who previously led the neural engineering program at the US National Institutes of Health, emphasized that the technology is still in its nascent stages following implantation, indicating that significant learning curves exist for both Neuralink and the implant recipient to optimize the control and information extraction from the device.
However, Ludwig acknowledged the tangible benefits for the patient, noting their newfound ability to interact with a computer, an interaction that was impossible prior to receiving the Neuralink implant. He remarked, “It’s certainly a good starting point,” recognizing the progress and potential benefits while maintaining a cautious outlook on the current state of the technology.
Despite the optimism surrounding Neuralink’s potential, the technology has faced scrutiny due to ethical concerns, particularly regarding animal testing. Reports have highlighted the extensive use of animals in developing the interface, with allegations of severe distress and physical harm.
However, Arbaugh remains hopeful about the future implications of Neuralink, acknowledging that while the technology is not without flaws, it represents a significant step forward in enhancing the quality of life for individuals with severe mobility restrictions. He envisions the technology as a game-changer, encouraging others to consider participating in human trials or contributing to the project in some way.
(With inputs from agencies)

if(allowedSurvicateSections.includes(section) || isHomePageAllowed){ (function(w) { var s = document.createElement('script'); s.src=" s.async = true; var e = document.getElementsByTagName('script')[0]; e.parentNode.insertBefore(s, e); })(window); }

}

window.TimesApps = window.TimesApps || {}; var TimesApps = window.TimesApps; TimesApps.toiPlusEvents = function(config) { var isConfigAvailable = "toiplus_site_settings" in f && "isFBCampaignActive" in f.toiplus_site_settings && "isGoogleCampaignActive" in f.toiplus_site_settings; var isPrimeUser = window.isPrime; if (isConfigAvailable && !isPrimeUser) { loadGtagEvents(f.toiplus_site_settings.isGoogleCampaignActive); loadFBEvents(f.toiplus_site_settings.isFBCampaignActive); loadSurvicateJs(f.toiplus_site_settings.allowedSurvicateSections); } else { var JarvisUrl=" window.getFromClient(JarvisUrl, function(config){ if (config) { loadGtagEvents(config?.isGoogleCampaignActive); loadFBEvents(config?.isFBCampaignActive); loadSurvicateJs(config?.allowedSurvicateSections); } }) } }; })( window, document, 'script', );

[ad_2]

Source link

Back to top button